Ieq Capital LLC Takes Position in Clover Health Investments, Corp. (NASDAQ:CLOV)


Ieq Capital LLC bought a new position in Clover Health Investments, Corp. (NASDAQ:CLOV – Get Rating) in Q1, according to its latest filing with the Securities and Exchange Commission. The company bought 17,466 shares of the company, valued at around $62,000.

A number of other hedge funds and other institutional investors also changed their stock holdings. FNY Investment Advisers LLC increased its position in Clover Health Investments by 3,500.0% in the fourth quarter. FNY Investment Advisers LLC now owns 7,200 shares of the company worth $26,000 after acquiring an additional 7,000 shares during the period. Pictet Asset Management SA increased its position in Clover Health Investments by 75.5% in the fourth quarter. Pictet Asset Management SA now owns 18,750 shares in the company worth $70,000 after acquiring an additional 8,065 shares during the period. Performa Ltd US LLC increased its position in Clover Health Investments by 733.3% in the fourth quarter. Performa Ltd US LLC now owns 10,000 shares of the company worth $37,000 after acquiring an additional 8,800 shares during the period. Principal Financial Group Inc. increased its position in Clover Health Investments by 56.7% in the fourth quarter. Principal Financial Group Inc. now owns 28,230 shares of the company worth $105,000 after acquiring an additional 10,214 shares during the period. Finally, Teamwork Financial Advisors LLC bought a new position in Clover Health Investments in the fourth quarter worth approximately $38,000. 23.26% of the shares are held by institutional investors.

CLOV opened at $2.44 on Friday. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt ratio of 0.04. Clover Health Investments, Corp. has a 1-year minimum of $1.95 and a 1-year maximum of $11.13. The company has a market capitalization of $1.15 billion, a PE ratio of -1.67 and a beta of 1.75. The company’s 50-day simple moving average is $2.44 and its two-hundred-day simple moving average is $2.79.

Clover Health Investments (NASDAQ:CLOV – Get Rating) last released its quarterly results on Monday, May 9. The company reported ($0.19) earnings per share for the quarter, beating the consensus estimate of ($0.24) by $0.05. The company posted revenue of $874.38 million for the quarter, versus a consensus estimate of $815.42 million. Clover Health Investments recorded a negative net margin of 28.64% and a negative return on equity of 112.18%. Stock analysts expect Clover Health Investments, Corp. will show -1.04 earnings per share for the current fiscal year.

Clover Health Investment Profile (Get a rating)

Clover Health Investments, Corp. operates as the insurer of Medicare Advantage in the United States. The Company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for Medicare-eligible consumers. It also focuses on non-insurance related activities.

See also

Want to see which other hedge funds hold CLOV? Visit HoldingsChannel.com for the latest 13F filings and insider trading for Clover Health Investments, Corp. (NASDAQ:CLOV – Get Rating).

Institutional ownership by quarter for Clover Health Investments (NASDAQ:CLOV)



Receive daily news and reviews for Clover Health Investments – Enter your email address below to receive a concise daily summary of the latest news and analyst notes for Clover Health Investments and related companies with MarketBeat.com’s FREE daily newsletter.